新型补体抑制剂对大鼠肾移植缺血再灌注损伤的治疗作用

Complement inhibition by a novel membrane targeted complement regulator improve renal function after rat kidney transplantation

  • 摘要: 目的:观察新型补体抑制剂APT070对大鼠肾移植缺血再灌注损伤的治疗作用。方法:应用同基因大鼠肾脏移植模型,供肾移植前分别经观察药物APT070、对照药物APT898、相应蛋白多肽链及灌注液灌注,测定术后1-7 d肾脏功能。结果:肾移植术后1-2 d,APT070灌注组移植肾功能明显好于对照组(P<0.05)。结论:APT 070作为一种可与肾脏组织结合的新型补体抑制剂,可减轻肾脏缺血再灌注损伤。

     

    Abstract: Objective: to observe the effects of a novel membrane targeted complememt regulator on renal function after rat kidney transplantation. Methods: Donor kidneys were perfused with APT070, APT898, peptides, and Collins solution before isograft kidney transplantation. Renal functions were measured 1. 7 days after transplantation. Results: Renal functions were significantly improved by perfusing donor kidney with APT070, P<0.05. Conclusion: APT070, a novel membrane targeted complement regulator can prevent ischemia/reperfusion injury and facilitate short term renal function in rat isograft model.

     

/

返回文章
返回